Amring Pharmaceuticals Inc, was born of a long legacy of trust, respect and success. The company is committed to putting people first in all it does, providing high-quality generic medications and excellent customer service at a reasonable cost.

Amring is supported by a trusted, privately held, global pharmaceutical company with a 65-year-plus history of quality, value, and success. Amring builds on this stellar legacy, while also distinguishing itself as a multinational resource for reliable generic medications and a sustainable global business in its own right.

As a private company focused on supplying specialized and unique products in targeted markets, Amring offers a simple value proposition to customers, partners, and the pharmaceutical marketplace: It leverages every opportunity to meet specific customer demands with value-added generic medicines. The company’s customer service is second to none, as it is a tight, well-connected group that can respond quickly to requests from both customers and partners.

Amring has strategically positioned itself to make and market affordable products that add value.

The company is already invested in Desmopressin Acetate, a peptide-based drug that can treat indications such as diabetes insipidus as well as certain bedwetting problems and bleeding disorders, and Tranexamic Acid, a product to treat certain bleeding disorders in women. Amring is actively seeking to add more products to its portfolio.

The company’s leadership team brings significant experience in generic pharmaceuticals and related industries. Amring’s senior pharmaceutical executives have proven success in building businesses from the ground up, a keen ability to quickly maximize global resources at a local level, and the commitment and experience to support long-term sustainable relationships. The company’s broad capabilities can also fill the gaps in pharmaceutical development, manufacturing, marketing, and distribution.

Backed by a notable heritage of accomplishment in the pharmaceutical industry, Amring looks forward to growing and bringing more dependable, high-quality generic pharmaceutical products to the marketplace.
 
For more information, visit amringusa.com.